weight loss drugs other than glp-1 Medication Guide: Wegovy vs Ozempic vs Saxenda Half of GLP-1 users ditch
Description
More consistent medication access When cost barriers fall, patients are more likely to stay on treatment long enough to experience meaningful results
The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism
Notably, ablation of vagal inputs, whether by surgical or chemical methods, has been shown to block the appetite-suppressing effects of peripheral GLP-1 in rodent models (Abbott et al., 2005
Accessed November 13, 2023
